Advancing data science in drug development through an innovative computational framework for data sharing and statistical analysis
Abstract Background Novartis and the University of Oxford’s Big Data Institute (BDI) have established a research alliance with the aim to improve health care and drug development by making it more efficient and targeted. Using a combination of the latest statistical machine learning technology with...
Enregistré dans:
Auteurs principaux: | Ann-Marie Mallon, Dieter A. Häring, Frank Dahlke, Piet Aarden, Soroosh Afyouni, Daniel Delbarre, Khaled El Emam, Habib Ganjgahi, Stephen Gardiner, Chun Hei Kwok, Dominique M. West, Ewan Straiton, Sibylle Haemmerle, Adam Huffman, Tom Hofmann, Luke J. Kelly, Peter Krusche, Marie-Claude Laramee, Karine Lheritier, Greg Ligozio, Aimee Readie, Luis Santos, Thomas E. Nichols, Janice Branson, Chris Holmes |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d43dee580b834d6ca85817e178bae918 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Maternal sociodemographic characteristics, early pregnancy behaviours, and livebirth outcomes as congenital heart defects risk factors - Northern Ireland 2010-2014
par: Hafi Saad, et autres
Publié: (2021) -
The Spatiotemporal Data Fusion (STDF) Approach: IoT-Based Data Fusion Using Big Data Analytics
par: Dina Fawzy, et autres
Publié: (2021) -
Views on Open Data Business from Software Development Companies
par: Herala,Antti, et autres
Publié: (2018) -
Efficient IoT Data Management for Geological Disasters Based on Big Data-Turbocharged Data Lake Architecture
par: Xiaohui Huang, et autres
Publié: (2021) -
Exploratory data analysis in the context of data mining and resampling.
par: Chong Ho Yu
Publié: (2010)